What are the most common causes of frequent clotting of arteriovenous fistulas and synthetic grafts in hemodialysis patients with end‑stage renal disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Frequent Arteriovenous Fistula and Graft Thrombosis

The primary cause of frequent clotting in both arteriovenous fistulas (AVFs) and grafts (AVGs) is unrecognized hemodynamically significant stenosis, which accounts for approximately 90% of access thromboses. 1

Primary Anatomic Cause: Venous Stenosis

Hemodynamically significant stenosis is the dominant mechanism driving thrombosis in dialysis access. The rate of thrombosis is largely determined by the presence of unrecognized stenotic lesions that progress undetected. 1

  • Venous anastomotic stenosis is the most common site of stenosis in AVGs, caused by intimal hyperplasia at the graft-vein junction 2, 3, 4
  • Each fistula type has characteristic stenosis locations related to significant angulation, which creates turbulent flow and intimal injury 2
  • Early detection and treatment of stenosis reduces thrombosis frequency by up to 70% and significantly lowers access replacement rates 1

Secondary Non-Anatomic Causes

While stenosis accounts for 90% of cases, the remaining 10% of thromboses result from: 1

  • Hypotension post-hemodialysis - reduced perfusion pressure leads to stasis and clot formation 1
  • Hypercoagulable states - underlying thrombophilia increases clotting risk 1
  • Decreased cardiac output - inadequate flow through the access circuit 1
  • Access site infection - inflammatory changes promote thrombosis 1

Differential Risk Between Access Types

Synthetic grafts thrombose at twice the rate of native fistulas:

  • Target thrombosis rate for AVGs: ≤0.5 episodes per patient-year 1
  • Target thrombosis rate for AVFs: ≤0.25 episodes per patient-year (after initial 2-month maturation period) 1
  • Native fistulas have inherently lower thrombosis rates compared to prosthetic grafts 1

Surveillance Strategy to Prevent Thrombosis

Systematic monitoring for stenosis is essential to prevent thrombosis:

  • Physical examination should assess for adequate thrill, signs of stenosis, and abnormal findings at each dialysis session 5, 6
  • Sequential flow measurements can detect deterioration of access function before thrombosis occurs 1
  • Intra-access pressure monitoring identifies hemodynamically significant stenosis 6
  • Doppler ultrasound confirms stenosis location and severity when clinical suspicion exists 6, 2

Critical Pitfall to Avoid

The most common error is failure to detect and treat stenosis before thrombosis occurs. Dialysis centers should maintain thrombosis rates below the guideline thresholds (0.5 for grafts, 0.25 for fistulas) through ongoing quality assurance programs that examine thrombosis rates and underlying causes. 1 When thrombosis occurs more than twice within a single month, or when correctable stenosis recurs, vascular surgery consultation for access revision should be obtained. 1

Hemodynamic Factors Contributing to Stenosis Formation

The arteriovenous anastomosis creates abnormal hemodynamic forces that drive stenosis development:

  • Altered blood flow velocity and wall shear stress near the anastomosis site causes endothelial dysfunction 7
  • Abnormal cyclic stretch promotes vascular smooth muscle cell proliferation 7
  • These hemodynamic disturbances lead to intimal hyperplasia and adverse vascular remodeling 7, 3
  • Significant angulation at characteristic stenosis sites creates turbulent flow and intimal injury 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Arteriovenous Fistulas and Their Characteristic Sites of Stenosis.

AJR. American journal of roentgenology, 2015

Research

Prosthetic arteriovenous grafts for hemodialysis.

The journal of vascular access, 2009

Research

Arteriovenous graft for hemodialysis, graft venous anastomosis closure - current state of knowledge. Minireview.

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2015

Guideline

Vascular Access with Lower Infection Risk in Hemodialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Stenosis in hemodialysis arteriovenous fistula: evaluation and treatment.

Hemodialysis international. International Symposium on Home Hemodialysis, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.